00:42:10 EST Wed 20 Feb 2019
Enter Symbol
or Name
USA
CA



Login ID:
Password:
Save
Blissco Cannabis Corp
Symbol C : BLIS
Shares Issued 102,380,171
Close 2019-01-10 C$ 0.30
Recent Sedar Documents

Blissco signs distribution deal with Pharmadrug

2019-01-11 08:04 ET - News Release

Mr. Damian Kettlewell reports

A BLISSCO SIGNS DISTRIBUTION AGREEMENT WITH PHARMADRUG IN GERMANY

Blissco Cannabis Corp. has entered into strategic partnership with Pharmadrug Production GmbH for distribution of Blissco's product in Germany.

Pharmadrug will actively promote Blissco's dried cannabis product across its expansive medical cannabis network in the German market. Pharmadrug is a private pharmaceutical company headquartered in Hamburg, Germany, and an international distributor and manufacturer for pharmaceutical products in the Middle East, Africa and Europe.

"We are excited to partner with Pharmadrug and enter the German market. Building international partnerships is a key component of Blissco's growth strategy, and we are looking forward to hosting German inspectors for a good manufacturing practice (GMP) inspection of the Blissco facility in late January," said Damian Kettlewell, chief executive officer of Blissco.

A successful GMP inspection is required to earn a GMP certification which will enable Pharmadrug and Blissco to apply for import and export permits to begin shipping. Germany is the largest legal cannabis market in the world with a population of over 82 million people who have federal insurance coverage for cannabis.

"As a German entrepreneur, I very much appreciate the pleasant and efficient co-operation with Blissco. We are proud and confident to bring such a dedicated team into the growth-oriented German market," said Pharmadrug chief executive officer Thomas Raab.

About Blissco Cannabis Corp.

Blissco Cannabis is a Canadian wellness cannabis brand based in British Columbia and a licensed producer, processor and distributor of premium dried cannabis and cannabis oil.

Blissco is committed to providing distinguished service to its medical clients and plans to launch a telemedicine app to offer mobile access to a nurse practitioner for easy guidance and access to a prescription for medical cannabis products. Blissco is also developing an e-commerce website for its medical clients that will house a curated shop of premium dried cannabis, cannabis oil and related products. Blissco will be selling adult-use dried cannabis and processed products in Canadian provinces.

We seek Safe Harbor.

© 2019 Canjex Publishing Ltd. All rights reserved.